PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 306 participants.

Also called NCT04045873

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 306 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04045873
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04045873. Randomized; no masking; primary purpose treatment. Start 2019-12 (anticipated); primary completion 2021-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI
Condition
Heart Failure
Intervention (Device)
extracorporeal membrane oxygenation
Lead sponsor
Xijing Hospital (class: other)
Collaborator
The First Affiliated Hospital of Zhengzhou University (class: other)
Collaborator
Bethune International Peace Hospital (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
The Second Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
The General Hospital of Northern Theater Command (class: other)

Record details

Record id
cardio:ct-nct04045873
Content hash
8ffa5c580d83ab5fad31979b5b697b93e36a00cf54b8743d25866192af51dbd9